Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 499 entries
View as:

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005972 Org: User:
Start: 05/31/00 End: 02/29/08 Due: 02/28/09

Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00009789 Org: User:
Start: 12/31/00 End: 06/30/10 Due: 06/30/11

Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00268489 Org: User:
Start: 05/31/06 End: 04/30/10 Due: 04/30/11

Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

Phase: N/A Priority: Normal
NCT ID: NCT00897663 Org: User:
Start: 11/30/06 End: 01/31/18 Due: 01/31/19

T-DM1 and Tucatinib Compared with T-DM1 Alone in Preventing Relapses in People with High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

Phase: N/A Priority: Normal
NCT ID: NCT04457596 Org: User:
Start: 03/02/21 End: 05/31/35 Due: 05/31/36

Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005059 Org: User:
Start: 01/31/00 End: 04/30/06 Due: 04/30/07

Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2

Phase: N/A Priority: Normal
NCT ID: NCT00896701 Org: User:
Start: 01/31/04 End: 04/30/14 Due: 04/30/15

Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00089310 Org: User:
Start: 09/30/04 End: 04/30/09 Due: 04/30/10

Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

Phase: N/A Priority: Normal
NCT ID: NCT00003118 Org: User:
Start: 10/31/97 End: 03/31/00 Due: 03/31/01

Study of Tissue Samples From Patients With Stage I Non-Small Cell Lung Cancer Enrolled on Research Study CALGB-140202

Phase: N/A Priority: Normal
NCT ID: NCT00990873 Org: User:
Start: 07/31/09 End: 11/30/14 Due: 11/30/15

CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01545687 Org: User:
Start: 04/30/12 End: - Due: -

Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01190449 Org: User:
Start: 08/31/11 End: 10/15/20 Due: 10/15/21

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00553150 Org: User:
Start: 03/31/09 End: 11/15/19 Due: 11/15/20

Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03578081 Org: User:
Start: 11/20/18 End: 05/01/23 Due: 05/01/24

A Clinical Study Evaluating the Benefit of Adding Rucaparib to Enzalutamide for Men with Metastatic Prostate Cancer That Has Become Resistant to Testosterone-Deprivation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04455750 Org: User:
Start: 10/14/21 End: 09/30/27 Due: 09/30/28

Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01814813 Org: User:
Start: 06/19/13 End: 05/22/23 Due: 05/22/24

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00002924 Org: User:
Start: 01/31/97 End: 06/30/06 Due: 06/30/07

Pulmonary Rehabilitation Before Lung Cancer Resection

Phase: N/A Priority: Normal
NCT ID: NCT02887521 Org: User:
Start: 02/28/18 End: 09/25/19 Due: 09/25/20

Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease

Phase: N/A Priority: Normal
NCT ID: NCT00031720 Org: User:
Start: 03/31/02 End: 11/30/13 Due: 11/30/14

Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01473290 Org: User:
Start: - End: - Due: -

PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01515787 Org: User:
Start: 06/12/12 End: 06/30/24 Due: 06/30/25

Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00899704 Org: User:
Start: 03/31/08 End: 03/31/08 Due: 03/31/09

Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00023686 Org: User:
Start: 10/31/01 End: 04/30/04 Due: 04/30/05

Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002762 Org: User:
Start: 06/30/96 End: 10/31/09 Due: 10/31/10

Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00031980 Org: User:
Start: 03/31/02 End: 05/31/05 Due: 05/31/06